BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Hernández-Bartolomé A, López-Rodríguez R, Borque MJ, González-Moreno L, Real-Martínez Y, García-Buey L, Moreno-Otero R, Sanz-Cameno P. Angiopoietin-2/angiopoietin-1 as non-invasive biomarker of cirrhosis in chronic hepatitis C. World J Gastroenterol 2016; 22(44): 9744-9751 [PMID: 27956798 DOI: 10.3748/wjg.v22.i44.9744]
URL: https://www.wjgnet.com/1948-5182/full/v22/i44/9744.htm
Number Citing Articles
1
Amira Isaac, Tarek Maged El Sakaty, Sarah Hamdan Hussein, Hany Samir Rasmy. Angiopoietin-2 as a predictor of fibrosis regression in chronic hepatitis C virus patients after direct-acting antiviral drugsThe Egyptian Journal of Internal Medicine 2021; 33(1) doi: 10.1186/s43162-021-00086-5
2
Savneet Kaur, Sadam Hussain, Kailash Kolhe, Guresh Kumar, Dinesh M. Tripathi, Arvind Tomar, Pratibha Kale, Ashad Narayanan, Chaggan Bihari, Meenu Bajpai, Rakhi Maiwall, Ekta Gupta, Shiv K. Sarin. Elevated plasma ICAM1 levels predict 28-day mortality in cirrhotic patients with COVID-19 or bacterial sepsisJHEP Reports 2021; 3(4): 100303 doi: 10.1016/j.jhepr.2021.100303
3
Zhong-Bin Xia, Fan-Ru Meng, Yu-Xuan Fang, Xia Wu, Chun-Wang Zhang, Ying Liu, Dan Liu, Guo-Qing Li, Fan-Bo Feng, Hai-Yang Qiu. Inhibition of NF-κB signaling pathway induces apoptosis and suppresses proliferation and angiogenesis of human fibroblast-like synovial cells in rheumatoid arthritisMedicine 2018; 97(23): e10920 doi: 10.1097/MD.0000000000010920
4
Krizia Pocino, Cecilia Napodano, Mariapaola Marino, Riccardo Di Santo, Luca Miele, Nicoletta De Matthaeis, Francesca Gulli, Raffaele Saporito, Gian Ludovico Rapaccini, Gabriele Ciasca, Umberto Basile. A Comparative Study of Serum Angiogenic Biomarkers in Cirrhosis and Hepatocellular CarcinomaCancers 2021; 14(1): 11 doi: 10.3390/cancers14010011
5
Melania Manco, Nadia Panera, Annalisa Crudele, Maria Rita Braghini, Marzia Bianchi, Donatella Comparcola, Rita De Vito, Giuseppe Maggiore, Anna Alisi. Angiopoietin-2 levels correlates with disease activity in children with nonalcoholic fatty liver diseasePediatric Research 2022; 91(7): 1781 doi: 10.1038/s41390-021-01666-5
6
Maham Farshidpour, Spencer Pace, Michael L. Volk. The clinical value of angiopoietin‐2 in liver diseasesClinical Liver Disease 2022; 19(6): n/a doi: 10.1002/cld.1218
7
Alessia Virzì, Victor Gonzalez-Motos, Simona Tripon, Thomas F. Baumert, Joachim Lupberger. Profibrotic Signaling and HCC Risk during Chronic Viral Hepatitis: Biomarker DevelopmentJournal of Clinical Medicine 2021; 10(5): 977 doi: 10.3390/jcm10050977
8
Amr Shaaban Hanafy, Emad Eldin Shaaban, Sheren Al Zahaby. Predictors of Fibrosis Progression in Chronic Active Hepatitis C Related NephropathyEMJ Hepatology 2019; : 86 doi: 10.33590/emjhepatol/10314484
9
David Bauer, Karin Kozbial, Philipp Schwabl, David Chromy, Benedikt Simbrunner, Albert F. Stättermayer, Matthias Pinter, Petra Steindl-Munda, Michael Trauner, Peter Ferenci, Thomas Reiberger, Mattias Mandorfer. Angiopoietin 2 levels decrease after HCV-cure and reflect the evolution of portal hypertensionDigestive and Liver Disease 2022; 54(9): 1222 doi: 10.1016/j.dld.2022.02.013
10
Leona Radmanić, Snježana Zidovec-Lepej. The Role of Stem Cell Factor, Epidermal Growth Factor and Angiopoietin-2 in HBV, HCV, HCC and NAFLDLife 2022; 12(12): 2072 doi: 10.3390/life12122072
11
Savneet Kaur, Sadam Hussain, Kailash Kolhe, Guresh Kumar, Dinesh M Tripathi, Arvind Tomar, Pratibha Kale, Ashad Narayanan, Chaggan Bihari, Meenu Bajpai, Rakhi Maiwall, Ekta Gupta, Shiv Kumar Sarin. Elevated Plasma Levels of ICAM1 Predict Mortality in COVID-19 and Sepsis Patients with Liver CirrhosisSSRN Electronic Journal 2020;  doi: 10.2139/ssrn.3741508
12
Nancy G. Casanova, Vivian Reyes-Hernon, Taylor Gregory, Belinda Sun, Tadeo Bermudez, Matthew K. Hufford, Radu C. Oita, Sara M. Camp, Gabriela Hernandez-Molina, Jorge Rojas Serrano, Xiaoguang Sun, Jocelyn Fimbres, Mehdi Mirsaeidi, Saad Sammani, Christian Bime, Joe G. N. Garcia. Biochemical and genomic identification of novel biomarkers in progressive sarcoidosis: HBEGF, eNAMPT, and ANG-2Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.1012827
13
Mariya A. Derbak, Nataliya V. Lizanets, Oksana T. Hanych, Olesya M. Horlenko, Hanna Y. Mashura, Serhii O. Boiko, Nad’a Rozumyková. DYNAMICS OF FIBROTIC CHANGES IN THE LIVER AFTER THE SUCCESSFUL ERADICATION OF HEPATITIS C VIRUS IN PATIENTS WITH NAFLDWiadomości Lekarskie 2022; 75(10): 2392 doi: 10.36740/WLek202210113
14
Yosuke Osawa, Sachiyo Yoshio, Yoshihiko Aoki, Masaaki Korenaga, Masatoshi Imamura, Takashi Oide, Miku Okawara, Hironari Kawai, Yuriko Tsutsui, Yuichi Yoshida, Shiori Yoshikawa, Taizo Mori, Taiji Yamazoe, Tatsuya Kanto. Blood angiopoietin-2 predicts liver angiogenesis and fibrosis in hepatitis C patientsBMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-01633-8
15
Roberto Carmagnani Pestana, Manal M. Hassan, Reham Abdel-Wahab, Yehia I. Abugabal, Lauren M. Girard, Donghui Li, Ping Chang, Kanwal Raghav, Jeff Morris, Robert A. Wolff, Asif Rashid, Hesham M. Amin, Ahmed Kaseb. Clinical and prognostic significance of circulating levels of angiopoietin-1 and angiopoietin-2 in hepatocellular carcinomaOncotarget 2018; 9(102): 37721 doi: 10.18632/oncotarget.26507
16
Leona Radmanić, Kristian Bodulić, Petra Šimičić, Adriana Vince, Snježana Židovec Lepej. The Effect of Treatment-Induced Viral Eradication on Cytokine and Growth Factor Expression in Chronic Hepatitis CViruses 2022; 14(8): 1613 doi: 10.3390/v14081613